Self-Organizing Hydrogel Matrix for Biocompatible Tissue Engineering
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current synthetic hydrogel systems for biomedical applications lack tunability and biocompatibility, often being too soft for construction processes and potentially toxic due to their interaction with biological systems, and they can elicit an immune response.
Innovation Solution
A non-covalent self-organizing hydrogel matrix formed by a covalent polymer-peptide conjugate with a repeating dipeptide motif (BA)n, where B is a positively charged amino acid, allowing for the creation of hydrogels with varying physical, chemical, and biological properties through simple modifications in the peptide sequence.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If synthetic polymers are used to create durable structures, then mechanical strength and durability are improved, but biocompatibility and similarity to biological systems deteriorate
Solution Approach 1:
The patent creates a composite hydrogel system combining synthetic polymers (PEG, polyvinyl alcohol, PLGA) with natural bio-macromolecules (collagen, gelatin, hyaluronic acid, heparin). This composite approach allows the synthetic components to provide mechanical durability and structural stability while the natural components provide biocompatibility, cell adhesion properties, and biological functionality. The synergistic combination resolves the contradiction between strength and biocompatibility.
Solution Approach 2:
The patent applies different material properties to different regions or functions within the hydrogel system. Synthetic polymer segments provide mechanical strength and structural framework, while natural polymer segments provide biocompatibility and biological activity. This local differentiation of material qualities allows each component to optimize its specific function, resolving the overall contradiction between durability and biocompatibility.
2Reliability
If biomaterials from living sources are used, then biocompatibility is improved, but chemical composition definition and control deteriorate
Solution Approach 1:
The patent segments the hydrogel system into distinct synthetic and natural polymer components, each with defined functions. The synthetic polymers (PEG, PLGA, polyvinyl alcohol) provide controlled, well-defined chemical compositions and degradation rates, while the natural polymers (collagen, gelatin, hyaluronic acid) provide biocompatibility. This segmentation allows independent optimization and precise control of each component's properties while maintaining overall system functionality.
Solution Approach 2:
The patent utilizes the ability to modify parameters such as molecular weight, degradation rate, crosslinking density, and polymer concentration to achieve desired hydrogel properties. By controlling these parameters in both synthetic and natural polymer components, the patent achieves both defined chemical composition and high biocompatibility, resolving the contradiction between manufacturing precision and biological compatibility.
3Ease of operation
If non-covalent self-assembling systems are used, then ease of cell embedding is improved, but structural stability may deteriorate
Solution Approach 1:
The patent creates a continuous network structure through the self-assembling interaction between complementary peptide sequences (e.g., RGD motifs) and corresponding receptor sites on natural polymers. This continuous crosslinked network, formed by non-covalent interactions such as hydrogen bonding, hydrophobic interactions, and electrostatic forces, provides both ease of cell embedding (due to gentle formation conditions) and structural stability (through extensive network formation). The multivalent interactions ensure structural integrity while maintaining biocompatibility.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The hydrogel system is biocompatible, tunable, and stable, enabling controlled degradation and protein binding, making it suitable for biomedical applications without the risks of toxicity or immune response, and can be produced at a low cost.
Implementation Method 1
non-covalent self-organizing hydrogel matrix
Implementation Method 2
B is an amino acid with a positively charged side chain
Data Source
Figure 1
Figure 2a~3b
Figure 4a
AI summary
The invention relates to a non-covalent, self-organising hydrogel matrix for biotechnological applications, containing a covalent polymer peptide conjugate, wherein the covalent polymer peptide conjugate comprises conjugates of two or more peptides that are coupled to a polymer chain, and the peptide sequence contains a recurring dipeptide motif (BA)n, wherein B is an amino acid havaing a positively charged side chain, A is alanine and n is an integer between 4 and 20.